SIGA Technologies Inc. | Ownership
Companies that own SIGA Technologies Inc.
Jet Capital Investors LP
3,680,000
4.65%
-1,018,095
3.18%
06/30/2018
Nantahala Capital Management LLC
2,466,840
3.12%
-3,543,409
1.46%
06/30/2018
BlackRock Fund Advisors
2,309,743
2.92%
2,302,379
0%
06/30/2018
The Vanguard Group, Inc.
1,847,637
2.33%
1,847,637
0%
06/30/2018
SSgA Funds Management, Inc.
808,394
1.02%
808,394
0%
06/30/2018
Legato Capital Management LLC
551,535
0.7%
0
0.82%
06/30/2018
Northern Trust Investments, Inc.
518,454
0.66%
506,579
0%
06/30/2018
Geode Capital Management LLC
487,951
0.62%
487,951
0%
06/30/2018
AltraVue Capital LLC
468,794
0.59%
325,410
8.25%
06/30/2018
Charles Schwab Investment Management, Inc.
236,206
0.3%
236,206
0%
06/30/2018
| Address |
31 East 62nd Street
New York New York 10065
United States
|
|
Employees
|
- |
| Website |
http://www.siga.com |
| Updated |
07/08/2019 |
| SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. |
